1432
M. Hong and C. Cai
Vol 46
Table 3
Typical procedure for the preparation of 7-benzylidene-
4-phenyl-3,4,6,7-tetrahydro-1H- cyclopenta[d] pyrimidin-
2(5H)-one. A mixture of benzaldehyde (0.212 g, 2 mmol),
cyclopentanone (0.168 g, 2 mmol), urea (0.146 g, 2.4 mmol),
and Yb(NPf2)3 (0.062 g, 0.02mmol) in perfluo-rodecalin
(C10F18, cis and trans-mixture, 2mL) was well stirred at 90ꢀC
for appropriate time. After the reaction was completed, the
system was cooled to room temperature. Then, the perfluorode-
calin on the bottom was separated for the next cycle. Water
was added to the reaction mixture, and the pure product was
obtained by filtration followed by washing with acetone, ethyl
acetate, and alcohol. Selected data: 7-benzylidene-4-phenyl-
3,4,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-2(5H)-one, pale
Synthesis of benzylidene heterobicyclic pyrimidinones in the presence
a
of Yb(Npf2)3 in C10F18.
Entry
Ar
X
Time (h) Product Yieldb (%)
1
2
3
Ph
O
O
O
O
O
O
O
O
S
2
3
3
3
2
2
2
2
6
6
5
1a
1b
1c
1d
1e
1f
1g
1h
1i
91
93
81
85
89
84
83
92
94
86
92
4-CH3C6H4
2-CH3C6H4
4-OCH3C6H4
4-ClC6H4
2-ClC6H4
4-BrC6H4
4-NO2C6H4
Ph
4
5
6
7
8
1
yellow solid; mp 236–239ꢀC; H NMR (500 MHz, DMSO): d
9
10
11
4-CH3C6H4
4-ClC6H4
S
1j
1k
¼ 1.97–2.01 (m, 1H), 2.49 (m, 1H), 2.71–2.82 (m, 2H), 5.15
13
S
(s, 1H), 6.63 (s, 1H), 7.21–7.38 (m, 11H), 8.78 (s, 1H).
C
NMR: d ¼ 29.5, 29.8, 58.7, 117.8, 119.6, 127.2, 127.4, 128.6,
129.0, 129.5, 129.6, 137.1, 138.8, 140.3, 144.3, 154.4 ppm.
MS (EI) m/z 303 [MþH]þ.
a Reaction conditions: aldehyde (2 mmol), cyclopentanone (2 mmol),
thiourea or urea (2.4 mmol), C10F18(2 mL), 90ꢀC.
b Isolated yield.
EXPERIMENTAL
REFERENCES AND NOTES
Chemicals used were obtained from commercial suppliers
1
[1] Weber, L. Curr Med Chem 2002, 9, 2085.
[2] Hulme, C.; Gore, V. Curr Med Chem 2003, 10, 51.
[3] Karina, S.; Matus, A.; Fourrey, J. L.; Clivio, P. J Chem
Soc, Perkin Trans 2002, 1, 774.
and used without further purifications. H NMR, 13C, and 19F
NMR spectra were recorded with a Bruker Advance RX500
spectrometer. Mass spectra were recorded on
a Saturn
2000GC/MS instrument. Inductively coupled plasma (ICP)
spectra were measured on an Ultima2C apparatus. Elemental
analyses were performed on a Yanagimoto MT3CHN recorder.
[4] Sasaki, S.; Cho, N.; Nara, Y.; Harada, M.; Endo, S.; Suzuki,
N.; Furuya, S.; Fujino, M. J Med Chem 2003, 46, 113.
[5] Li, L. H.; Wallace, T. L.; Richard, K. A.; Tracey, D. Can-
cer Res 1985, 45, 532.
Typical
procedure
for
preparation
of
(C8F17SO2)2NH. (C8F17SO2)2NH was prepared according to
the literature [15,16]. Ammonia (300 mmol) was transferred
with stirring perfluorooctanesulfonyl fluoride (50 g, 99.6
mmol) at ꢁ20ꢀC for about 1 h, it was then continued at room
temperature for 1 h. The solid product was acidified with HCl
followed by addition of Et2O. The organic layer was dried
over anhydrous Na2SO4 and concentrated under reduced pres-
sure, dried in vacuum at 80ꢀC for 16 h to give C8F17SO2NH2
(87% yield). Then the mixture of perfluorooctanesulfonyl fluo-
ride (45.4 g, 91 mmol), perfluorooctanesulfonamide (43.4 g,
87 mmol), and Et3N (76 mL) was heated at reflux for 23 h.
The lower brown fluorous layer was washed with 10% HCl
and dried in vacuum at 70ꢀC for 6 h to afford (C8F17SO2)2N
HNEt3. Finally, through acidic ion exchange resin column,
(C8F17SO2)2N HNEt3 changed to afford (C8F17SO2)2NH in
50% yield. Anal. Calcd. for (C8F17SO2)2NH: C,19.57; N: 1.43
H: 0.10. Found: C, 19.61; N: 1.45, H, 0.16. 19F NMR: d-
126.2, -121.8, -114.0, -81.2.
[6] Bartolini, S.; Mai, A.; Artico, M.; Paesano, N.; Rotili, D.;
Spadafora, C.; Sbardella, G. J Med Chem 2005, 48, 6776.
[7] (a) Chen, Q.; Jiang, L.-L.; Chen, C.-N.; Yang, G.-F. J. Het-
erocycl Chem 2009, 46, 139; (b) Zhu, Y.-L.; Huang, S.-L.; Pan, Y.-J.
Eur J Org Chem 2005, 2354.
[8] (a) Lorand, T.; Deli, J.; Szabo, D.; Foeldesi, A.; Zschunke,
A. Pharmazie 1985, 40, 536; (b) Elgemeie, G. E. H.; Attia, A. M. E.;
Alkabai, S. S. Nucleos Nucleot Nucl 2000, 19, 723.
[9] (a) Hammam, A. E. G.; Sharaf, M. A.; El-Hafez, N. A. A.
Indian J Chem Sect B 2001, 40, 213; (b) Al-Omran, F.; Al-Awadi, N.
J Chem Res 1995, 10, 2201; (c) Al-Omar, M. A.; Youssef, K. M.;
El-Sherbeny, M. A.; Awadalla, S. A. A.; El-Subbagh, H. I. Arch
Pharm (Weinheim Ger.) 2005, 338, 175; (d) Ali, M. I.; Hammam, A.
E. G.; Youssef, N. M. J Chem Eng Data 1981, 26, 214.
[10] Zhang, H.-H.; Zhou, Z.-Q.; Yao, Z.-G.; Xu, F.; Shen, Q.
Tetrahedron Lett 2009, 50, 1622.
[11] Hao, X. H.; Yamazaki, O.; Yoshida, A.; Nishikido, J. Tetra-
hedron Lett 2003, 44, 4977.
Typical
procedure
for
preparation
of
[12] Mikami, K.; Matumoto, Y.; Nishikido, J.; Yamamoto, F.;
Nakajima, H. Tetrahedron Lett 2001, 42, 289.
Yb(NPf2)3. Ytterbium bis(perfluorooctanesulfonyl)imide com-
plex, Yb(NPf2)3 was prepared according to the reported proce-
dure [17]. The mixture of Yb2O3 (0.118 g, 0.3 mmol) and bis
(perfluorooctanesulfonyl)imide (0.883 g, 0.9 mmol) in H2O (10
mL) at 110ꢀC for 1 h. The resulting mixture was filtered through
a membrane filter. The remaining water was removed under
reduced pressure at 80ꢀC for 16 h. The Ytterbium bis (perfluor-
ooctanesulfonyl)imide complex was obtained in 98% yield. ICP:
Calcd for C48O12N3F102S6Yb: Yb, 5.56. Found: 5.60 Anal.
Calcd. For Yb[N(SO2C8F17)2]3: C, 18.50; N, 1.35. Found: C:
18.45; N, 1.41. 19F NMR: d ꢁ126.1, ꢁ121.2, ꢁ114.2, ꢁ81.4.
[13] Hao, X. H.; Yoshida, A.; Nishikido, J. Tetrahedron Lett
2004, 45, 781.
[14] Hao, X. H.; Yoshida, A.; Nishikido, J. Tetrahedron Lett
2005, 46, 2697.
[15] Hao, X. H.; Yoshida, A.; Nishikido, J. J Fluor Chem 2006,
127, 193.
[16] Benfodda, Z.; Delon, L.; Guillen, F.; Blancou, H. J Fluor
Chem 2007, 128, 1353.
[17] Mikami, K.; Kotera, O.; Motoyama, Y.; Tanaka, M. Inorg
Chem Commun 1998, 1, 10.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet